Sunita Keshari

7PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursBiomaterialsEnglish and literacy curriculum and pedagogy (excl. LOTE, ESL and TESOL)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 23, 2026
Spatial immune hubs defined by conserved activated dendritic cells are remodeled by immunotherapy.

Tomoyuki Minowa, Sunita Keshari, Shan He

|Feb 09, 2026
Antigen presentation requirements for effective cDC1-based cancer immunotherapy.

Josué E Pineda, Tomoyuki Minowa, Li Shen

|Nov 24, 2025
Bhlhe40 Coordinates T Cell Programs with Distinct CD4 and CD8 T Cell Requirements for Anti-PD-1 Versus Anti-CTLA-4.

Akata Saha, Tomoyuki Minowa, Alexander S Shavkunov

|Jan 08, 2024
Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy.

Sunita Keshari, Alexander S Shavkunov, Qi Miao

|Feb 19, 2022
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy.

Avery J Salmon, Alexander S Shavkunov, Qi Miao

|Feb 12, 2021
Probiotic Activity of Staphylococcus epidermidis Induces Collagen Type I Production through FFaR2/p-ERK Signaling.

Indira Putri Negari, Sunita Keshari, Chun-Ming Huang

Pageof 2

Frequent Collaborators

5 joint publications

Matthew M Gubin

4 joint publications

Josué E Pineda

4 joint publications

Ken Chen

4 joint publications

Akata Saha